HRTX (STOCKS)
Heron Therapeutics, Inc.
$0.906400
+0.053400 (+6.26%)
Prev close: $0.853000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Craig A. Collard
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $171.11M
- Employees
- 122
- P/E (TTM)
- -7.08
- P/B (TTM)
- 12.09
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $154.90M |
| Benefits Costs and Expenses | $175.10M |
| Cost Of Revenue | $41.35M |
| Costs And Expenses | $116.10M |
| Gross Profit | $113.56M |
| Nonoperating Income/Loss | -$17.66M |
| Operating Expenses | $116.10M |
| Research and Development | $12.43M |
| Other Operating Expenses | $103.67M |
| Operating Income/Loss | -$2.54M |
| Income/Loss From Continuing Operations After Tax | -$20.20M |
| Income/Loss From Continuing Operations Before Tax | -$20.20M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$20.20M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$20.20M |
| Net Income/Loss Available To Common Stockholders, Basic | -$20.20M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.12 |
| Diluted Earnings Per Share | -$0.12 |
| Basic Average Shares | 166,707,000 |
| Diluted Average Shares | 166,707,000 |
| Assets | $255.88M |
| Current Assets | $238.07M |
| Cash | $46.60M |
| Inventory | $92.75M |
| Prepaid Expenses | $11.80M |
| Other Current Assets | $86.92M |
| Noncurrent Assets | $17.81M |
| Fixed Assets | $12.40M |
| Other Non-current Assets | $5.41M |
| Liabilities | $241.54M |
| Current Liabilities | $96.10M |
| Accounts Payable | $8.99M |
| Wages | $9.27M |
| Other Current Liabilities | $77.83M |
| Noncurrent Liabilities | $145.45M |
| Equity | $14.33M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $14.33M |
| Liabilities And Equity | $255.88M |
| Net Cash Flow From Operating Activities | -$27.59M |
| Net Cash Flow From Operating Activities, Continuing | -$27.59M |
| Net Cash Flow From Investing Activities | $16.01M |
| Net Cash Flow From Investing Activities, Continuing | $16.01M |
| Net Cash Flow From Financing Activities | $14.43M |
| Net Cash Flow From Financing Activities, Continuing | $14.43M |
| Net Cash Flow | $2.85M |
| Net Cash Flow, Continuing | $2.85M |
| Comprehensive Income/Loss | -$20.20M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$20.20M |
| Other Comprehensive Income/Loss | -$9.00K |